Posts Tagged ‘startup’
Innosuisse Supports 7 Promising Swiss Health Valley Startups
Innosuisse has selected 39 new Startup Innovation Projects, providing direct funding to early-stage Swiss companies on the cusp of entering the market. These startups are driving innovation across diverse sectors, from pharma and life sciences to industrial applications and beyond. 7 are located in the Swiss Health Valley. Through its Startup Innovation Projects programme,…
Read MoreTop 100 Startups – the Swiss Health Valley is well represented
The Top100 Swiss Startup Ranking showcases the 100 Swiss startups with the most significant potential. Each year, a jury of 100 startup investors selects the most promising companies that are no older than five years after incorporation. The 2025 ranking reflects the strength, diversity, and innovative power of Switzerland’s startup ecosystem,” says Stefan Steiner,…
Read MoreFIF Funding Supports Four Life Sciences Startups: Reverso Therapeutics, Harantech, Vibrant and Joipaw
Four innovative startups from Geneva developing solutions in pet health, life sciences, and digital therapeutics have received support from the FONGIT Innovation Fund (FIF). Harantech and Reverso Therapeutics, both UNIGE spin-offs, along with Vibrant, a Wyss Center project, each received a CHF 50,000 FIF Grant to support the translation of their research into tangible health…
Read MoreHevelion, IRIS and Kymansis awarded by the FIT
The Fondation pour l’Innovation Technologique awards three life sciences projects from CHUV and EPFL: Hevelion from UNIL-CHUV, and IRIS and Kymansis from EPFL. They received CHF 100’000 Tech Grants to continue developing their technologies. Hevelion: spatial omics for new targeted therapies Hevelion is developing an AI-powered software platform to accelerate spatial biomarker discovery for…
Read MoreAzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme
Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics. AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…
Read MoreAzureCell Therapies secures CHF 150,000 from Venture Kick
AzureCell Therapies, a Biotech spin-off from the University of Geneva, has received CHF 150,000 from Venture Kick to deliver cell-based treatments that replace damaged neurons in Parkinson’s patients. Parkinson’s disease is an increasingly prevalent neurological disorder that affects over 10 million people worldwide. Current treatments only manage symptoms and fail to halt the disease’s…
Read MoreHilo by Aktiia Received FDA 510(k) Clearance for its Blood Pressure Monitor Wristband
The CSEM spinoff Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. Thi wearable uses an optical sensor to collect data from one’s wrist. The Hilo by Aktiia wrist wearable is one of a kind as it collects one’s blood…
Read MoreInTeeth Receives a CHF 100,000 FIF Seed Loan
InTeeth, a University of Geneva spinoff has developed a patented InLiner, the first-ever lingual aligner that is fixed behind the teeth. Three high-potential projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), reinforcing the canton’s support for breakthrough technologies in life sciences and precision engineering. InTeeth received a CHF 100,000…
Read MoreBeech Biotech Awarded $1.9 million by the Gates Foundation
Beech Biotech, a Lausanne-based biopharmaceutical company creating “Mother only” monoclonals to treat complications of pregnancy, has been awarded a $1.9 million grant by the Gates Foundation for the development of its breakthrough therapeutic approach in preeclampsia. Preeclampsia is a leading cause worldwide of maternal morbidity and mortality, premature birth, stillbirth, and neonatal death. Each…
Read MoreClee Medical, ProSeed & Berninox Shine at the 2025 >>venture>> Awards
The 2025 >>venture>> Award Ceremony at ETH Zurich brought together the brightest minds of Swiss innovation, with nearly 400 startups submissions and 18 finalists celebrated across six verticals. Among the standout innovators, three Swiss Health Valley startups were awarded. In the Health & Nutrition category, Clee Medical SA, a Geneva-based, Wyss Center spinoff, earned…
Read More